Cannabis use among cancer survivors before and during the COVID-19 pandemic, 2019-2021
JNCI Cancer Spectrum · 2023
DOI: 10.1093/jncics/pkad031 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2023. Verfasst von Sayantani Sarkar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Nursing, Yale University, New Haven, CT, USA. Hauptthemen laut MEDLINE: Cannabis, COVID-19, Cancer Survivors, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
We estimated the prevalence of past 30-day cannabis use, evaluated reasons for use, and identified individual-level factors associated with cannabis use among cancer survivors before (2019) and during (2020 and 2021) the COVID-19 pandemic. Cancer survivors, aged 18 years and older, were identified from the 2019 (n = 8185), 2020 (n = 11 084), and 2021 (n = 12 248) Behavioral Risk Factor Surveillance System. Prevalence of past 30-day cannabis use among survivors held steady through the pandemic (8.7%, 7.4%, and 8.4% in 2019, 2020 and 2021, respectively). Of those who used cannabis, 48.7% used it for medical reasons in 2019, 54.5% in 2020, and 43.5% in 2021. Survivors were more likely to report past 30-day cannabis use if they were younger, male, current or former tobacco smokers, and binge alcohol consumers and if they experienced poor mental health in the past 30-days. Our study identified subpopulations of cancer survivors that need to be targeted for evidence-informed discussions about cannabis use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Yale School of Nursing, Yale University, New Haven, CT, USA.
- Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, USA.
- Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, MA, USA.
- Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
- COPPER Center, Yale School of Medicine, New Haven, CT, USA.
ORCID-Profile: Sayantani Sarkar, Hermine Poghosyan
Zitieren
APA
Sarkar, S., Braun, I. M., Nayak, M., Bryan, A. D., & Poghosyan, H. (2023). Cannabis use among cancer survivors before and during the COVID-19 pandemic, 2019-2021. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkad031
Vancouver
Sarkar S, Braun IM, Nayak M, Bryan AD, Poghosyan H. Cannabis use among cancer survivors before and during the COVID-19 pandemic, 2019-2021. JNCI Cancer Spectrum. 2023. doi:10.1093/jncics/pkad031
BibTeX
@article{Sarkar2023,
author = {Sarkar, Sayantani and Braun, Ilana M and Nayak, Manan and Bryan, Angela D and Poghosyan, Hermine},
title = {Cannabis use among cancer survivors before and during the COVID-19 pandemic, 2019-2021},
journal = {JNCI Cancer Spectrum},
year = {2023},
doi = {10.1093/jncics/pkad031}
}
EUVIMED